2025 Cell & Gene Meeting on the Mesa
Explore our integrated CDMO and CRO solutions for advanced therapies
October 6-8, 2025 | Phoenix, Arizona
About Meeting on the Mesa
The Cell & Gene Meeting on the Mesa is the sector’s leading annual conference, bringing together senior executives and top decision-makers to advance cutting-edge research into cures. Attracting more than 2,000 attendees, it provides a platform for forming strategic industry partnerships.
Addressing the commercialization challenges facing the cell and gene therapy sector today, the event will cover topics ranging from clinical trial design and alternative payment models to scale-up and supply chain solutions for advanced therapies. We look forward to seeing you in Phoenix.
Event details
Date: October 6-8, 2025
Format: In-person
Location: Arizona Biltmore, A Waldorf Astoria Resort
Event website: https://meetingonthemesa.com/
Why Thermo Fisher Scientific?
Advanced therapeutics like cell and gene therapies have the potential to transform the pharmaceutical industry as we know it, but navigating drug discovery and development remains a long, costly, and high-risk process—especially for these more complex treatments. Leveraging the infrastructure and expertise of an experienced CDMO and CRO partner can help.
Our technical experts will be at Meeting on the Mesa for one-on-one discussions about Accelerator™ Drug Development, Thermo Fisher’s innovative 360° CDMO and CRO solutions. As the industry’s only fully integrated CDMO and CRO partner, our unique approach fosters collaboration and transparency across every phase, driving speed, simplicity, and scalability.
Some key services within this offering include:
- Translational research services
- Development and manufacturing of viral vectors, cell therapies, and mRNA
- Ultra-cold supply chain management
- Clinical research services
Attend our workshop
- Date: Tuesday, October 7, 2025
- Time: 8:00-9:00 a.m. PDT (60 minutes)
- Location: FLW Ballroom E
Scaling Smart: Collaborative commercialization and process automation approaches for dynamic markets
The burgeoning field of cell and gene therapy R&D holds immense promise for treating—and potentially curing—a wide range of genetic and chronic diseases. However, the path from groundbreaking research to widespread clinical application is fraught with challenges, particularly in the realm of manufacturing scale-up.
Scaling Smart will bring together leaders from industry, bio incubators, academia, and solutions providers to explore creative, collaborative strategies for robust, scalable, and cost-effective manufacturing. Discussion topics will include automation in unit operations and leveraging partnerships to accelerate drug development.
Attendees will gain actionable insights into:
- Overcoming technical hurdles in cell and gene therapy development
- Reducing Cost of Goods Sold (COGS) without compromising quality
- Building a blueprint to deliver next-generation therapies more efficiently
Panel Moderator:
- Betty Woo, Ph.D., Management Consultant, Cell, Gene and Advanced Therapies, Thermo Fisher Scientific
Panelists:
- Brian Shy, MD-Ph.D. – Lab Director, Cellular Transplantation GMP Facility, UCSF
- Wolfram Carius, Ph.D. – Executive Vice President and Head of Cell and Gene Therapy, Bayer
- Jennifer Cannon, Ph.D. – President Commercial Operations, Thermo Fisher Scientific
- Jennifer MacDonald, MD – Chief Operating Officer, Advanced Regenerative Manufacturing Institute
Let’s connect at Cell & Gene Meeting on the Mesa
Meet Thermo Fisher Scientific’s experts at Cell & Gene Meeting on the Mesa to explore our complete suite of CDMO and CRO services for advanced therapies.
Schedule a private meeting with our team during the event by clicking below.
Continuing education for the pharma industry
Follow us on social for event updates
We look forward to seeing you soon